4.62
price down icon12.08%   -0.635
 
loading
Schlusskurs vom Vortag:
$5.255
Offen:
$5.41
24-Stunden-Volumen:
160.18K
Relative Volume:
2.83
Marktkapitalisierung:
$30.58M
Einnahmen:
$5.75M
Nettoeinkommen (Verlust:
$-38.96M
KGV:
-0.3705
EPS:
-12.47
Netto-Cashflow:
$-32.63M
1W Leistung:
+14.36%
1M Leistung:
+13.79%
6M Leistung:
-33.81%
1J Leistung:
-28.37%
1-Tages-Spanne:
Value
$4.36
$5.90
1-Wochen-Bereich:
Value
$3.8217
$5.90
52-Wochen-Spanne:
Value
$2.92
$11.20

Kala Bio Inc Stock (KALA) Company Profile

Name
Firmenname
Kala Bio Inc
Name
Telefon
781-996-5252
Name
Adresse
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
KALA's Discussions on Twitter

Vergleichen Sie KALA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
KALA
Kala Bio Inc
4.62 30.58M 5.75M -38.96M -32.63M -12.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Kala Bio Inc Stock (KALA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-03-30 Herabstufung JP Morgan Neutral → Underweight
2021-08-06 Herabstufung JP Morgan Overweight → Neutral
2020-09-14 Herabstufung Jefferies Buy → Hold
2020-07-23 Eingeleitet Northland Capital Outperform
2020-06-01 Fortgesetzt Oppenheimer Outperform
2020-05-27 Bestätigt H.C. Wainwright Buy
2020-03-09 Hochstufung BofA/Merrill Neutral → Buy
2019-12-17 Herabstufung BofA/Merrill Buy → Neutral
2019-03-14 Eingeleitet Jefferies Buy
Alle ansehen

Kala Bio Inc Aktie (KALA) Neueste Nachrichten

pulisher
Jun 06, 2025

Millennium Management LLC Purchases 17,130 Shares of HBT Financial, Inc. (NASDAQ:HBT) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Decreases Stake in KALA BIO, Inc. (NASDAQ:KALA) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Nexa Resources S.A. (NYSE:NEXA) Shares Sold by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

24,353 Shares in T. Rowe Price Floating Rate ETF (NYSEARCA:TFLR) Acquired by Bank of America Corp DE - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Cadre Holdings, Inc. (NYSE:CDRE) Shares Acquired by Millennium Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Acquires 2,612 Shares of First Trust Indxx Global Natural Resources Income ETF (NASDAQ:FTRI) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Sells 1,791 Shares of Bluerock Homes Trust, Inc. (NYSEAMERICAN:BHM) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Buys 11,012 Shares of Liberty All-Star Growth Fund, Inc. (NYSE:ASG) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Kala Bio director Mark Iwicki sells $40,638 in stock - Investing.com India

Jun 05, 2025
pulisher
Jun 04, 2025

KALA BIO Executives Sell Shares - TradingView

Jun 04, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 03, 2025

KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

KALA: Oppenheimer Announces Outperform Rating for Kala Bio | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | KALA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 01, 2025

Tidal Investments LLC Has $269,000 Stake in Air Lease Co. (NYSE:AL) - Defense World

Jun 01, 2025
pulisher
Jun 01, 2025

Aegon Ltd. (NYSE:AEG) Shares Sold by Millennium Management LLC - Defense World

Jun 01, 2025
pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Reveal Latest Eye Disease Pipeline Progress at Major Jefferies Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 26, 2025

Q1 Earnings Estimate for KALA BIO Issued By HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

HC Wainwright Lowers KALA BIO (NASDAQ:KALA) Price Target to $12.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Kala Bio stock target cut to $12 by H.C. Wainwright, retains buy - Investing.com Nigeria

May 24, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bi - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bio | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 15, 2025

KALA BIO: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

Persistent Epithelial Defect Market on Track for Major - openPR.com

May 14, 2025
pulisher
May 14, 2025

KALA Focuses on Advancing KPI-012 Development Amid Pivotal Trials | KALA Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025 - The Manila Times

May 14, 2025
pulisher
May 14, 2025

KALA's PCED Drug Could Reach 100,000 PatientsQ3 Trial Results Coming - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Q2 EPS Forecast for Design Therapeutics Reduced by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Datadog Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Cadre Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Equities Analysts Issue Forecasts for Cryoport Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Forecasts Lower Earnings for Denali Therapeutics - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimates for Core Scientific Lifted by HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Fox Factory Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

KALA BIO (KALA) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 Earnings Forecast for Cryoport Issued By Leerink Partnrs - Defense World

May 12, 2025
pulisher
May 11, 2025

KALA BIO (KALA) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Fluence Energy, Inc. (NASDAQ:FLNC) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 08, 2025
pulisher
May 07, 2025

Dimensional Fund Advisors LP Sells 5,772 Shares of Turning Point Brands, Inc. (NYSE:TPB) - Defense World

May 07, 2025
pulisher
May 04, 2025

Head-To-Head Survey: Equillium (NASDAQ:EQ) and KALA BIO (NASDAQ:KALA) - Defense World

May 04, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Has $426,000 Stake in Sidus Space, Inc. (NASDAQ:SIDU) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025

Finanzdaten der Kala Bio Inc-Aktie (KALA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Kala Bio Inc-Aktie (KALA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Reumuth Mary
CHIEF FINANCIAL OFFICER
Jun 24 '25
Sale
4.01
3,631
14,560
62,100
Bazemore Todd
SEE REMARKS
Jun 24 '25
Sale
4.01
4,058
16,273
83,699
Brazzell Romulus K
SEE REMARKS
Jun 24 '25
Sale
4.01
5,251
21,057
82,698
Iwicki Mark T
Director
Jun 24 '25
Sale
4.01
13,227
53,040
258,433
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):